Scinovex
articleTop 1% cited

The window of therapeutic opportunity in multiple sclerosis

Journal of Neurology · 2005 · Vol. 253(1) · pp. 98–108
Alasdair ColesAmanda CoxEmmanuelle Le PageJoanne JonesS. Anand TripJ. DeansShaun R. SeamanDavid H. MillerG HaleHerman WaldmannD. A. S. Compston
Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersRheumatoid Arthritis Research and TherapiesMultiple sclerosisMedicineAtrophyNeurologyLesionInflammationNeuroradiologyClinically isolated syndromeAlemtuzumabExpanded Disability Status Scale

MeSH terms

AlemtuzumabAntibodies, MonoclonalAntibodies, NeoplasmChildChild, PreschoolDisability EvaluationDrug Administration ScheduleFemaleHumansInfantMagnetic Resonance ImagingMaleMultiple SclerosisRetrospective StudiesTime Factors

Funding

  • Wellcome Trust
  • Multiple Sclerosis Society
  • Takeda Oncology
  • Medical Research Council
Citations
504
FWCI
16.41
field-weighted impact
References
67
Percentile
100%
vs. same field & year
Citations per year
Related articles
The window of therapeutic opportunity in multiple sclerosis
Journal of Neurology · 2005 · 504 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.